Non-aspirin non-steroidal anti-inflammatory medications have been found to have a negative impact on overall and progression-free survival time for mRCC patients...
The post Use of NSAIDs reduces progression-free survival of patients with mRCC appeared first on European Pharmaceutical Review.
Original Article: Use of NSAIDs reduces progression-free survival of patients with mRCC